Tirzepatide White Powder

Pigment Yellow 13

Butanamide,2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(2,1-diazenediyl)]bis[N-(2,4-dimethylphenyl)-3-oxo-;C.I. Pigment Yellow 13;Butanamide,2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxo-;2,2′-[(3,3′-Dichloro[1,1′-biphenyl]-4,4′-diyl)bis(2,1-diazenediyl)]bis[N-(2,4-dimethylphenyl)-3-oxobutanamide];C.I. 21100;Benzidine Yellow 20544;Benzidine Yellow GE;Benzidine Yellow GR;Benzidine Yellow Lemon 12221;Dainichi Benzidine Yellow 2GR;Elkon Fast Yellow GR;Helio Fast Yellow GRF;Helio Fast Yellow GRN;Hostaperm Yellow GR;Irgalite Yellow BAW;Irgalite Yellow BAWX;Irgaplast Yellow IRS;Isol Benzidine Fast Yellow GRX;Isol Benzidine Fast Yellow GRX spec;Kromon Yellow GXR;Latexol Fast Yellow JR;Light Yellow JBR;Monolite Fast Yellow GLV;Monolite Yellow GL;Monolite Yellow GLA;Permanent Yellow GR;Pigment Yellow 13;Pigment Yellow MH;Polymo Yellow GR;Recolite Fast Yellow BLF;Recolite Fast Yellow BLT;Rubber Fast Yellow GRA;Sanyo Light Fast Benzidine Yellow R;Saranac Yellow X 2838;Symuler Fast Yellow GRF;Tertropigment Fast Yellow VGR;Tertropigment PGR;Vulcan Fast Yellow GR;Vulcan Fast Yellow GRA;Vulcan Fast Yellow GRN;Vynamon Yellow GRE;Yellow Toner YB 5;Vynamon Yellow GRES;Isol Benzidene Yellow GRX 2548;Diarylide Yellow;Symuler Fast Yellow GRTF;Segnale Light Yellow GRX;Isol Diaryl Yellow GRF;Graphtol Yellow RGS;Sico Fast Yellow D 1355;1264-07-9;12642-91-0;61614-29-7;108563-17-3;196522-51-7;1859910-22-7

5102-83-0

C36H34Cl2N6O4

InChIKey=IAFBRPFISOTXSO-UHFFFAOYSA-N

629.49

685.60

225-822-9

O8RYS681QI

5336

DTXSID0029268

Specialty Drugs

141.78000

7.78

DryPowder; OtherSolid; WetSolid

1.29

312-320°C

799.5ºC at 760mmHg

437.3ºC

1.632

<0.1 g/100 mL at 22 ºC

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

Dual agonist — GIPR, GLP-1R

FDA-approved (Mounjaro / Zepbound)

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

0.934 nM

0.0224 nM

Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

Mounjaro, Zepbound (approved 2022-05-13)

CHEMBL4297839

DB15171

D11360

PubChem

NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.